Please provide your email address to receive an email when new articles are posted on . The key to better understanding the efficacy vs. effectiveness gap in drug therapies could lie in real-world ...

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the ...

Two posters presented at AMCP Nexus 2022 addressed the cost-effectiveness of guideline-recommended integrase strand transfer inhibitor–based triple therapy in people living with HIV, as well as the ...

Please provide your email address to receive an email when new articles are posted on . Patients treated in real-world settings had significantly worse survival outcomes for six of seven regimens ...

This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.

The updated bivalent COVID-19 booster vaccine increased protection against symptomatic disease compared with the original monovalent vaccine given as recently as two months ago. That’s the takeaway ...